Natco beats rivals with Rs 1,290 semaglutide launch as Novo Nordisk patent expires
Hyderabad-based drug maker Natco Pharma is launching semaglutide injection in the form of multidose vials on Saturday – the first day of innovator Novo Nordisk’s patent expiry - priced between Rs 1,290 to Rs 1,750 per month depending on the dosage, the …